loader
Please Wait
Applying Filters...

Seqens Seqens

X

Looking for MolPort-001-779-881? Find Direct Compression used in MolPort-001-779-881 to address drug delivery challenges on PharmaCompass.

Filters Filter
Cross PopUp
FILTER :

filter

01 SPI Pharma (2)

02 Alcedo Pharmachem (1)

03 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd (1)

04 BASF (29)

05 Ulanqab Kema New Material (3)

filter

01 Capsule (7)

02 Granule / Pellet (8)

03 Orodispersible Tablet (4)

04 Suppository (1)

05 Tablet (14)

06 Topical Film (1)

07 Transdermal Patch (1)

filter

01 China (4)

02 Germany (29)

03 India (1)

04 U.S.A (2)

Close
4

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

Dosage Form: Capsule, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Sodium Lauryl Sulfate

Dosage Form: Capsule, Tablet

Category: Direct Compression, Granulation, Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for tablets.

Ingredient(s): Crospovidone, Lactose, Povidone

Dosage Form: Granule / Pellet, Tablet

Category: Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph.Eur., USP/NF and JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.

Ingredient(s): Lactose, Povidone

Dosage Form: Granule / Pellet, Tablet

Category: Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF and J.P

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Maximum disintegration

Ingredient(s): Polyvinylpyrrolidone Crosslinked

Dosage Form: Capsule, Granule / Pellet, Tablet

Category: Direct Compression, Disintegrants & Superdisintegrants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Microprilled Poloxamer

Dosage Form: Tablet

Category: Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glyco

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.

Ingredient(s): Crospovidone, Mannitol, Polyvinyl Acetate

Dosage Form: Orodispersible Tablet

Category: Chewable & Orodispersible Aids, Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: 90 % mannitol, 5 % crospovidone, 5 % polyvinyl acetate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY